Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

  • This share is currently suspended. It was suspended at a price of 650.00
  • There is currently no data for HAT

Form 8.5 (EPT/RI)

15 May 2025 09:56

RNS Number : 8298I
Canaccord Genuity Limited
15 May 2025
Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

Β 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

H&T Group PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected to the Offeree

Β 

(d) Date dealing undertaken:

14 May 2025

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Β 

5p Ords

Β 

Β 

Sales

Β 

174

Β 

640p

Β 

640p

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

Β 

Β 

Date of disclosure:

15 May 2025

Contact name:

David Baker

Telephone number:

020 7523 4656

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FERKZGMKRKDGKZG
Date   Source Headline
11th Aug 20207:00 amRNSUNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS
22nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20204:35 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSH&T appoints Chris Gillespie as executive director
29th Jun 20207:00 amRNSCOVID-19 update
23rd Jun 20201:36 pmRNSNotification of major holdings
11th Jun 20208:44 amRNSNotice of Annual Report Posting
18th May 20207:00 amRNSAGM Results
23rd Apr 20207:00 amRNSDirector Dealings and Issue of Equity
6th Apr 20207:00 amRNSCOVID-19 Update
18th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20207:00 amRNSAnnual Financial Report
27th Jan 20207:00 amRNSTrading Update and Notice of Results
14th Jan 20207:00 amRNSBoard changes
19th Nov 201912:39 pmRNSNotification of major holdings
18th Nov 20197:00 amRNSFCA review
8th Nov 20194:40 pmRNSSecond Price Monitoring Extn
8th Nov 20194:35 pmRNSPrice Monitoring Extension
7th Nov 20194:40 pmRNSSecond Price Monitoring Extn
7th Nov 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20191:28 pmRNSAdditional Listing
30th Sep 20194:43 pmRNSAcquisition & Trading
18th Sep 20197:00 amRNSExecutive Director
5th Sep 20193:39 pmRNSAdditional Listing
13th Aug 20197:00 amRNSUnaudited Interim Condensed Financial Statements
7th Aug 20192:00 pmRNSNotice of Results
22nd Jul 20193:42 pmRNSFinancial Director
22nd Jul 201911:15 amRNSStephen Fenerty
12th Jul 20191:59 pmRNSNotification of Major Holdings
5th Jul 20195:39 pmRNSNotification of Major Holdings
2nd Jul 20197:00 amRNSResult of Placing
1st Jul 20194:35 pmRNSAcquisition and Placing
21st Jun 20197:00 amRNSNotice of Annual Report Posting
3rd May 20197:00 amRNSResult of AGM
23rd Apr 20197:00 amRNSAdditional Listing
4th Apr 20194:00 pmRNSDirector dealings and issue of equity
12th Mar 20197:00 amRNSPreliminary Results
23rd Jan 20197:00 amRNSTrading Update and Notice of Results
3rd Jan 20197:00 amRNSPerformance Share Plan Awards
21st Nov 20184:21 pmRNSNotification of Major Holdings
10th Oct 201812:00 pmRNSNotification of Major Holdings
11th Sep 20187:00 amRNSDirector/PDMR Shareholding
14th Aug 20187:00 amRNSInterim Results
27th Jul 20184:23 pmRNSIFRS 9 Transition Document
16th Jul 20184:18 pmRNSNotification of Major Holdings
20th Jun 201810:25 amRNSAdditional Listing
14th Jun 20185:32 pmRNSDirector Dealings
13th Jun 201812:19 pmRNSDirector Dealings
29th May 20184:14 pmRNSNotification of Major Holdings
29th May 20187:00 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.